Covalent Immobilization of Chiral Catalysts
by grafting on TentaGel7 or by microcontact printing on
silicon chips.8 The analogous pincer 1,3-bis[(S)-4-isopro-
pyloxazolin-2-yl]benzene was immobilized on Wang resin
by solid-phase synthesis.9 In this paper we present a
complete overview of our efforts on the immobilization
of pybox ligands on polystyrene resins through two
complementary approaches, polymerization and grafting,
together with the importance of the complex preparation
method in the ruthenium-catalyzed cyclopropanation
reaction.
pared from chelidamic acid (1) in four steps (Scheme 1)
following the classical route11 with only minor modifica-
tions. The vinyl group was introduced by a Stille coupling
between 4-bromopyridinebis(oxazoline) 5a and tributylvi-
nylstannane to give the 4-vinylpybox 6 in 65% isolated
yield. It is worth noting that the analogous 4-chloropybox
5b did not react under the same conditions. To move the
catalyst further from the polymeric backbone, three more
functionalized ligands were prepared. The reaction be-
tween 4-bromostyrene and Sn2Bu6 gave the air-stable
tributyl(4-vinylphenyl)stannane, which undergoes a Stille
coupling reaction with 4-bromopybox 5a to give to the
corresponding 4-(4-vinylphenyl)pybox 7 (Scheme 1) in
55% isolated yield.
Another strategy was envisaged to introduce a longer
spacer between the support and ligand. 4-Halopyridines
react readily in SNAr reactions, and this behavior was
found to be useful to introduce phenoxide anions.6 One
possibility was substitution with p-bromophenol in a
basic medium (Scheme 1), which led to the 4-(p-bro-
mophenoxy)pybox intermediate 8. The aryl bromo group
was suitable for Stille coupling with tributylvinylstan-
nane, leading to 4-(p-vinylphenoxy)pybox 9. However,
this compound was obtained in a lower isolated yield
because its high solubility in hexane made purification
difficult. A longer spacer can be introduced by reaction
with a hydroquinone derivative, 4-(4-vinylbenzyloxy)-
phenol, in a basic medium, leading to the substituted
pybox 10 (Scheme 1). In this case the yield is lower than
with other phenols due to the occurrence of side reactions
involving the hydroquinone derivative.
The polymers were prepared with the functionalized
monomer (m ) 6, 7, 9, or 10), styrene, and divinylben-
zene by block polymerization initiated by AIBN12 (Scheme
2). On the basis of previous results,5 toluene was chosen
as the solvent and the molar content of pybox was kept
constant at 7%. Highly cross-linked polymers (macrore-
ticular-type) were prepared by using 51% divinylbenzene
in the polymerization mixture. These materials are
denoted Pm51, where P stands for polymerized materials,
m is the pybox monomer, and the subscript is the cross-
linking degree (% of divinylbenzene). A gel-type polymer
was prepared from pybox monomer 6 by using only 2%
divinylbenzene (denoted as P62) for the sake of compari-
son with the Merrifield-grafted ligands. Most of the chiral
pybox was incorporated into the polymer, and the final
functionalization was in the range of 0.4-0.51 mmol g-1
(Table 1).
Immobilization of Chiral Pyridinebis(oxazoline)
Ligands by Grafting. The other general strategy to
immobilize chiral ligands through covalent bonding
involves the use of a preformed support. In the case of
polymers, the most widely used supports are probably
the Merrifield resins (MRs),13 which are poly(styrene-
divinylbenzene) polymers with a low cross-linking degree.
To tether the pybox ligand, it was necessary to introduce
Results and Discussion
Immobilization of Chiral Pyridinebis(oxazoline)
Ligands by Polymerization. In our preliminary paper,5
we reported the immobilization of pybox ligands by
polymerization. In that case it was necessary to introduce
a polymerizable vinyl group, and position 4 of the
pyridine ring was chosen to maintain the C2 symmetry
of the ligand, although it had been previously shown that
this is not a prerequisite to obtain good enantioselectivi-
ties.10 The key intermediates in the synthesis of 4-sub-
stituted pyridinebis(oxazolines) were the 4-bromo- and
4-chloropybox (5a and 5b) compounds, which were pre-
(3) (a) Burguete, M. I.; Fraile, J. M.; Garc´ıa, J. I.; Garc´ıa-Verdugo,
E.; Luis, S. V.; Mayoral, J. A. Org. Lett. 2000, 2, 3905-3908. (b)
Ferna´ndez, M. J.; Fraile, J. M.; Garc´ıa, J. I.; Mayoral, J. A.; Burguete,
M. I.; Garc´ıa-Verdugo, E.; Luis, S. V.; Harmer, M. A. Top. Catal. 2000,
13, 303-309. (c) Orlandi, S.; Mandoli, A.; Pini, D.; Salvadori, P. Angew.
Chem., Int. Ed. 2001, 40, 2519-2521. (d) Hallman, K.; Moberg, C.
Tetrahedron: Asymmetry 2001, 12, 1475-1478. (e) Rechavi, D.;
Lemaire, M. Org. Lett. 2001, 3, 2493-2496. (f) Clarke, R. J.; Shannon,
I. J. Chem. Commun. 2001, 1936-1937. (g) Burguete, M. I.; Fraile, J.
M.; Garc´ıa, J. I.; Garc´ıa-Verdugo, E.; Herrer´ıas, C. I.; Luis, S. V.;
Mayoral, J. A. J. Org. Chem. 2001, 66, 8893-8901. (h) Park, J. K.;
Kim, S.-W.; Hyeon, T.; Kim, B. M. Tetrahedron: Asymmetry 2001, 12,
2931-2935. (i) Burguete, M. I.; D´ıez-Barra, E.; Fraile, J. M.; Garc´ıa,
J. I.; Garc´ıa-Verdugo, E.; Gonza´lez, R.; Herrer´ıas, C. I.; Luis, S. V.;
Mayoral, J. A. Bioorg. Med. Chem. Lett. 2002, 12, 1821-1824. (j)
Corma, A.; Garc´ıa, H.; Moussaif, A.; Sabater, M. J.; Zniber, R.;
Redouane, A. Chem. Commun. 2002, 1058-1059. (k) D´ıez-Barra, E.;
Fraile, J. M.; Garc´ıa, J. I.; Garc´ıa-Verdugo, E.; Herrer´ıas, C. I.; Luis,
S. V.; Mayoral, J. A.; Sa´nchez-Verdu´, P.; Tolosa J. Tetrahedron:
Asymmetry 2003, 14, 773-778.
(4) (a) Ghosh, A. K.; Mathivanan, P.; Capiello, J. Tetrahedron:
Asymmetry 1998, 9, 1-45. (b) Fache, F.; Schulz, E.; Tommasino, M.
L.; Lemaire, M. Chem. Rev. 2000, 100, 2159-2232. (c) Yao, S.;
Johannsen, M.; Audrias, H.; Hazell, R. G.; Jørgensen, K. A. J. Am.
Chem. Soc. 1998, 120, 8599-8605. (d) Evans, D. A.; Kozlowski, M. C.;
Murry, J. A.; Burgey, C. S.; Campos, K. R.; Connel, B. N.; Staples, R.
J. J. Am. Chem. Soc. 1999, 121, 669-685. (e) Evans, D. A.; Burgey, C.
S.; Kozlowski, M. C.; Tregay, S. W. J. Am. Chem. Soc. 1999, 121, 686-
699. (f) Evans, D. A.; Barnes, D. M.; Johnson, J.; Lectka, S.; Matt, T.
P. V.; Miller, S. J.; Murry, J. A.; Norcross, R. D.; Shaughnessy, E. A.;
Campos, K. R. J. Am. Chem. Soc. 1999, 121, 7582-7594. (g) Aspinall,
H. C.; Greeves, N.; Smith, P. S. Tetrahedron Lett. 1999, 40, 1763-
1766. (h) Schaus, S. E.; Jacobsen, E. N. Org. Lett. 2000, 2, 1001-1004.
(i) Iwara, S.; Tsushima, S.; Shimada, T.; Nishiyama, H. Tetrahedron
2002, 58, 227-232.
(5) Cornejo, A.; Fraile, J. M.; Garc´ıa, J. I.; Garc´ıa-Verdugo, E.; Gil,
M. J.; Legarreta, G.; Luis, S. V.; Mart´ınez-Merino, V.; Mayoral, J. A.
Org. Lett. 2002, 4, 3927-3930.
(6) (a) Cornejo, A.; Fraile, J. M.; Garc´ıa, J. I.; Gil, M. J.; Mart´ınez-
Merino, V.; Mayoral, J. A. Mol. Diversity 2003, 6, 93-105. (b) Cornejo,
A.; Fraile, J. M.; Garc´ıa, J. I.; Gil, M. J.; Luis, S. V.; Mart´ınez-Merino,
V.; Mayoral, J. A. C. R. Chim. 2004, 7, 161-167.
(7) Lundgren, S.; Lutsenko, S.; Jo¨nsson, C.; Moberg, C. Org. Lett.
2003, 5, 3663-3665.
(8) Jo¨nsson, C.; Hallman, K.; Anderson, H.; Stemme, G.; Malkoch,
M.; Malmstro¨m, E.; Hult, A.; Moberg, C. Bioorg. Med. Chem. Lett. 2002,
12, 1857-1861.
(9) Weissberg, A.; Portnoy, M. Chem. Commun. 2003, 1538-1539.
(10) (a) Nishiyama, H.; Soeda, N.; Naito, T.; Motoyama, Y. Tetra-
hedron: Asymmetry 1998, 9, 2865-2869. (b) Cornejo, A.; Fraile, J. M.;
Garc´ıa, J. I.; Gil, M. J.; Mart´ınez-Merino, V.; Mayoral, J. A.; Salvatella,
L. Angew. Chem., Int. Ed. 2005, 44, 458-461.
(11) Nishiyama, H.; Yamaguchi, S.; Kondo, M.; Itoh, K. J. Org.
Chem. 1992, 57, 4306-4309.
(12) (a) Svec, F.; Fre´chet, J. M. J. Chem. Mater. 1995, 7, 707-715.
(b) Svec, F.; Fre´chet, J. M. J. Science 1996, 273, 205-211. (c) Xie, S.;
Svec, F.; Fre´chet, J. M. J. Chem. Mater. 1998, 10, 4072-4078. (d) Svec,
F.; Fre´chet, J. M. J. Ind. Eng. Chem. Res. 1999, 38, 34-48. (e) Hird,
N.; Hughes, I.; Hunter, D.; Morrison, M. G. J. T.; Sherrington, D. C.;
Stevenson, L. Tetrahedron 1999, 55, 9575-9584.
(13) Merrifield, R. B. J. Am. Chem. Soc. 1963, 85, 2149-2154.
J. Org. Chem, Vol. 70, No. 14, 2005 5537